Progesterone and Cortisol levels in plasma of patients with Amyotrophic Lateral Sclerosis (ALS): Correlation with Prognostic Factors and Survival

GARGIULO MONACHELLI G; MEYER M; RODRÍGUEZ G; GARAY L; SICA REP; DE NICOLA AF ; GONZALEZ DENISELLE, MC

Seefeld

Congreso; First International Syposium of the Journal: Hormone Molecular Biology and Clinical Investigation; 2010

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder. Worse prognostic factors in ALS are: a) advanced age; b) bulbar onset; c) short time between onset and diagnosis. Progesterone (PROG) has been associated with neuroprotective and promyelinating activities in injury, ischemia and degeneration of the central and peripheral nervous system (CNS and PNS). Cortisol, is connected to the response to stress situations and might contribute to neuronal damage. The goals of the study were i) to investigate whether PROG levels are modified by ALS prognostic factors; ii) to determine whether cortisol follows the same pattern. We determined serum steroid levels in 27 patients with sporadic ALS (sALS) and 21 controls. Both steroid hormones showed significantly increased levels in ALS patients versus controls (mean ± SEM: PROG ALS vs control: 0.54 ± 0.05 vs 0.39 ± 0.04 ng/ml, p<0.05; cortisol ALS vs control: 17.02 ± 1.60 vs 11.83 ± 1.38 mg/dl; p<0.05). A trend toward higher levels of PROG were demonstrated in spinal onset patients compared to bulbar onset (p=0.07), positive correlation with survival time (RRho=0.43, p=0.04) and a trend toward significance with time to diagnosis (RRho=0.36, p=0.06). These correlations have not been demonstrated for cortisol.  Conclusion: Elevated serum steroid levels in sALS were probably due to hyperfunction of the HPA axis. However, only PROG correlated with better prognostic factors. Future studies will determine if the different behavior of PROG and cortisol relate to any particular role they may play during the course of this motor neuron degenerative disease.